Omega Funds appears to be a financial services company, likely specializing in investment management or providing funding solutions. The name suggests that the company may offer a variety of funds, such as hedge funds, mutual funds, or private equity funds.

Otello Stampacchia

Omega Funds

16VC is a venture capital firm investing in early-stage companies across all sectors.

16VC

Four Cities Capital is a venture capital firm that invests in early-stage technology companies.

Four Cities Capital

Unanimous is a venture capital firm that invests in early-stage technology companies.

Unanimous

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs.

Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients.

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others.

Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories.

Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation.

Omega Funds has raised more than $2 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.

Please be mindful of scams presented by unauthorized individuals regarding fictitious positions, job offers and other misrepresentations.  We do not ask candidates to provide sensitive identifiable information via email.  If a person claiming to be an Omega recruiter reaches out to you regarding a job opportunity, please report it to our team by emailing  jf@omegafunds.com with the details.

Kronos Bio

Syros Pharmaceuticals

Sana Biotechnology

Nuvation Bio

Translate Bio

Invivyd

Amunix

Arcutis Biotherapeutics

Dicerna Pharmaceuticals

Editas Medicine

Beam Therapeutics

Chroma Medicine

CinCor Pharma

Evotec

The Omega Team had a wonderful afternoon cooking at CASPAR Shelters!

Discover how your team can also get involved in #CookinWithCASPAR by visiting https://lnkd.in/dwF2afW7

We're proud sponsors of the VC University scholarship, which supports aspiring VCs from underrepresented backgrounds who want to make a difference in the industry. We’re excited to welcome 40 recipients who were awarded full scholarships to join Cohort 15 starting Feb. 5! 
 
Cohort 15 is incredibly diverse across geography, gender, ethnicity, and age:
 
- 78% identify as people of color
- 68% identify as women or as nonbinary
- 15% identify as LGBTQ+
- 70% live outside CA, MA, and NY (the three states with the majority of VC activity)
 
https://lnkd.in/gSY-ym9Z 
 
Special thanks to program hosts Venture Forward, Berkeley Law Executive Education, and the National Venture Capital Association

Omega Funds continues to be proud sponsors of the VC University scholarship, which supports aspiring VCs from underrepresented backgrounds who want to make a difference in the industry. Today, we’re excited to welcome 40 recipients who were awarded full scholarships to join Cohort 14!

Cohort 14 scholarship class is incredibly diverse across geography, gender, ethnicity, and age:
 
- 83% identify as people of color
- 68% identify as women or as nonbinary
- 25% identify as LGBTQ+
- 68% live outside CA, MA, and NY (the three states with the majority of VC activity)
 
Get to know the C14 scholarship class! https://lnkd.in/gqQVhjSn

Special thanks to program hosts Venture Forward, Startup Law Initiative at Berkeley Law and the National Venture Capital Association.

Omega is a proud sponsor of the VC University scholarship, which supports aspiring VCs from underrepresented backgrounds who want to make a difference in the industry. We’re excited to congratulate the 40 full scholarship recipients on their entrance to the program! 

At a glance, the scholarship class: 

- 78% identify as people of color
- 63% identify as women or as nonbinary
- 25% identify as LGBTQ+
- 60% live outside CA, MA, and NY (the three states with the majority of VC activity)

https://lnkd.in/dUb_7MWQ 

Special thanks to program hosts Venture Forward, Startup Law Initiative at Berkeley Law the National Venture Capital Association.

Metric
Company Name	Omega Funds	16	Four Cities Capital	Unanimous
Symbol
MSH ID	COM:OMEGAFUNDS	CO:16VC	COM:FOURCITIESCAPITAL	VC:UNANIMOUS
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Financial Services & Finance	Financial Services & Finance	Financial Services & Finance
Industry	Financial Services	Venture Capital	Venture Capital	Venture Capital
Country	US	US	US	US
Stage				Grant
Employee Count	39
Website	omegafunds.com	16vc.co	fourcitiescapital.com	unanimous.vc
LinkedIn	omegafunds
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	18.00K	101	1.62K
Web Traffic Growth	52.88	-0.39	-0.39
Valuation
Raised Capital			224.59K

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:OMEGAFUNDS

Omega Funds

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue